Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23954)

• Formulation Name: Daclatasvir Dihydrochloride eq 30mg base tablet
• Company: Bristol-Myers Squibb

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Daclatasvir	(DMSFK9V)	Hepatitis C virus infection	1E51.1	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	(E00625)	Not Available	Disintegrant
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent